Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on May 10, 2007
"This is an important step forward for the patients suffering from Parkinson's disease. Following approval and launch within Europe, Neupro will now be available for patients in the USA", comments Iris Loew-Friedrich, MD, PhD,
CSO SCHWARZ PHARMA AG. "We intend to submit a supplemental New Drug Application for the treatment of advanced Parkinson's disease to the FDA by the end of 2007."
Rotigotine is designed to mimic the action of dopamine, a naturally-produced neurotransmitter crucial for proper motor functioning.
Source: Schwarz Pharma (pdf)
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/68474
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for FDA Approves Neupro Transdermal Patch Against Parkinson's Disease:
|
Rating: 9.00 out of 1 vote(s) cast.
|
Response from:
Edward
(05/16/07 2:23pm)
Response from:
Johnson Chen
(01/16/08 5:53pm)
HealthLat is inviting patients who take Neupro, and physicians who prescribe it to report their experiences with the new drug. Your experiences will help patients needed and make money for you.
You are also welcome to check how Neupro has been used by other patients. It is free.
For details, please visit: http://www.healthlat.com
You are also welcome to check how Neupro has been used by other patients. It is free.
For details, please visit: http://www.healthlat.com
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
as well.
It's very exciting, especially when you take into account the current success Rotigotine is having with Parkinson's patients in the European market.
Barring anything unseen, it looks like we'll have the convenience of ONE daily dose by June!!!